-2%
Aproxi 40 treats nausea and vomiting caused by chemotherapy. Aproxi 40 prevents vomiting by blocking cytotoxic chemotherapeutic agents. It does that by requisitioning brain NK1 receptors. It enhances the antiemetic activity of 5-HT3-receptor antagonist ondansetron and the corticosteroid reason.
Aproxi 40 is classified as an anti-emetic medication. It is prescribed to prevent nausea and vomiting associated with chemotherapy (anti-cancer treatments) in adults and adolescents aged 12 years and older. Nausea refers to a sensation of discomfort in the stomach that often precedes vomiting, which is the involuntary or voluntary expulsion of stomach contents through the mouth.
Aproxi 40 contains Aprepitant, which works by blocking a chemical in the nervous system responsible for triggering vomiting. By doing so, it effectively helps prevent nausea and vomiting.
Aproxi 40 should be taken exactly as directed by your doctor. It is advised to continue taking the medication for the prescribed duration. Some common side effects may include headache, constipation, loss of appetite, fatigue, indigestion, and hiccups. These effects are usually mild and tend to resolve on their own, but if they persist or worsen, consult your doctor.
Before taking this medication, inform your doctor if you have any allergies to Aproxi 40 or other medicines. This medication is not recommended for children under 12 years of age.